Treatment Options in Metastatic Castration-Resistant Prostate Cancer: A Year In Review

home / insights / treatment-options-in-metastatic-castration-resistant-prostate-cancer-a-year-in-review

Dr. Neal Shore reviews treatment options in metastatic castration-resistant prostate cancer available in 2020.

Recent Content

Genomic test can predict resistance to chemotherapy in prostate cancer

177Lu-rhPSMA-10.1 injection shows positive radiation dosimetry results in mCRPC

Phase 3 data of oral sulopenem for uUTIs published in NEJM Evidence

FDA grants RMAT designation to detalimogene voraplasmid for high-risk NMIBC

Contact Info

2 Commerce Drive
Cranbury, NJ 08512